Menu ×

HEALTHCARE & PHARMACEUTICAL

Long Read Sequencing Market Segmentation By Technology {Single-Molecule Real-Time Sequencing (SMRT) and Nanopore Sequencing}; By Product (Instruments, Consumables and Services); By Workflow (Pre-Sequencing, Sequencing and Data Analysis); By Application (Identification & Fine Mapping of Structural Variation, Tandem Repeat Sequencing, Pseudogene Discrimination, Resolve Allele Phasing and Others) and By End User – Global Industry Demand Analysis and Opportunity Assessment 2018-2028

  • Text Size:

Extensive insights into the Growth of Long Read Sequencing Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More
IN THE NEWS
  • February 2020: NuProbe Global has signed an agreement with Oxford Nanopore Technologies. The collaboration will support the expanding use of Oxford Nanopore sequencing in applications such as cancer.

  • April 2020: Pacific Biosciences of California, Inc. announced that it has added PacBio Sequel II System to the genomics services portfolio of Inqaba Biotec. The Sequel II System offers highly accurate long reads, with 15x more data as compared to the original Sequel System.

Market Overview

The growth of the global long read sequencing market is thriving on the back of the recent advancement in the third-generation long-read sequence analysis technique. The advancement in technology is expected to enhance the screening of the genetic disorders bringing a new era in the field of medical science. Furthermore, the increasing healthcare expenditure in various countries across the world is also expected to promote towards the growth of the global long read sequencing market. Moreover, the long read sequencing market is witnessing a rapid growth currently owing to the significant growth in the prevalence of genetic disorders globally, followed by the rising number of key players operating in the segment which is also resulting in the increase in the number of patients opting for long read sequencing, which is further expected to boost the market growth.

The global long read sequencing market reached USD 819 million in the year 2018 and is expected to garner USD 7073.65 million by the end of 2025 by registering a CAGR of 23.99% across the globe over the forecast period 2021-2028. Additionally, the market is anticipated to gain an incremental $ opportunity of USD 246.65 million in the year 2020 as compared to the previous year. On the other hand, the market is also anticipated to grow by 4.5x and gain an absolute $ opportunity of USD 5503.39 million during the forecast period.

Growth Highlights based on Region during 2019-2028

The global long read sequencing market is segmented by regions into North America, Latin America, Europe, Asia-Pacific and Middle East and Africa. Among these regions, the market of North America registered the largest market share of 40.89% in the year 2019 and is expected to achieve a CAGR of 24.21% during the forecast period. The market in the region is further anticipated to gain an incremental $ opportunity of USD 101.41 million in the year 2020 as compared to the previous year and is further expected to cross USD 2935.15 million by the end of 2028. Additionally, the market in the region is anticipated to grow by 4.56x and gain an absolute $ opportunity of USD 2291.54 million during the forecast period. CLICK TO DOWNLOAD SAMPLE REPORT

Long Read Sequencing Market Graph

The study further incorporates Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

Market Segmentation Synopsis

By Technology

The global long read sequencing market has been segmented on the basis of technology into single-molecule real-time sequencing (SMRT) and nanopore sequencing. The single-molecule real-time sequencing (SMRT) segment held the largest market share and reached a market value of USD 527.01 million in the year 2018. Additionally, the segment is expected to achieve a CAGR of 23.68% during the forecast period and cross a value of USD 4438.17 million by the end of 2028. Further, the segment is anticipated to gain an incremental $ opportunity of USD 156.26 million in the year 2020 as compared to the previous year. On the other hand, the segment is also anticipated to grow by 4.42x and further gain an absolute $ opportunity of USD 3435.4 million during the forecast period.

Long Read Sequencing Market Graph

Market Drivers and Challenges

Growth Indicators

Increasing Prevalence of Genetic Disorders

The growing occurrences of genetic disorders is one of the primary reasons of deaths globally as notified by the World Health Organization. The growing prevalence of the genetic disorders is anticipated to create a surge in demand for long read sequencing methods, thus contributing to the market growth. Furthermore, the monogenic diseases have affected millions of people worldwide which has created concern among the public. According to the World Health Organization, over 10,000 of the diseases are known to be monogenic caused by single error in a single gene in the human DNA. Additionally, the long read sequencing also are highly recommended in cases where repeat disease or complex chromosomal rearrangements are suspected. The long read sequencing can further assist patients in monitoring their condition empowering them to more readily work with healthcare providers to manage their conditions and improve care. This factor is further projected to drive the market growth in the forthcoming years.

On the other hand, the increasing implementation of Next Generation Sequencing (NGS) technologies is one of the major factors driving the growth of the market. The implementation of NGS in the field of medical genetics has gained immense acceptance over the years owing to their high efficacy in screening genetic disorders, which is expected to drive the market growth. Currently, long read sequencing (LRS) techniques are being used to offer improvement in the characterization of the genetic variations that are difficult to access by using the current NGS approaches. The long read sequencing (LRS) technology is also used to detect genetic orders with previously known or suspected disease loci. Such factors are anticipated to drive the growth of the global long read sequencing market.

Barriers

High Cost of the Long Read Sequencing Procedure

Although the long read sequencing market has witnesses significant growth over the recent years, there are certain factors that may limit the expansion of the market in the upcoming years. For instance, the high cost associated with the long read sequencing procedures in anticipated to pose moderate threat to the growth of the market. Furthermore, the lack of proper healthcare infrastructure in various countries due to low healthcare expenditure is also projected to negatively impact the growth of the market in low income countries.

Competitive Landscape

Some of the affluent industry leaders in the global long read sequencing market are Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., FG Technologies, Stratos Genomics, QIAGEN, Takara Bio Inc., Quantapore, Inc. and BaseClear B.V.

FREQUENTLY ASKED QUESTIONS

Global Long Read Sequencing Market

1. Introduction

1.1. Market Definition

1.2. Product Overview

2. Assumptions And Acronyms

3. Research Methodology

4. Executive Summary- Global Long Read Sequencing Market

5. Regulatory Landscape

6. Value Chain Analysis

7. Market Dynamics

7.1. Growth Drivers

7.2. Key Trends

7.3. Key Market Opportunities

7.4. Major Roadblocks For The Market Growth

8. Industry Risk Analysis

8.1. Demand Risk Analysis

8.2. Supply Risk Analysis

9. Evaluation On The Impact Of Covid-19 On The Global Long Read Sequencing Market

10. Global Long Read Sequencing Market

10.1. Market Size (USD million), 2018-2028

> Segmentation by Technology

· Single-molecule Real-time Sequencing (SMRT) and Nanopore Sequencing, Market Size (USD million), 2018-2028

> Segmentation by Product

· Instruments, Consumables and Services, Market Size (USD million), 2018-2028

> Segmentation by Workflow

· Pre-sequencing, Sequencing and Data Analysis, Market Size (USD million), 2018-2028

> Segmentation by Application

· Identification & Fine Mapping Of Structural Variation, Tandem Repeat Sequencing, Pseudogene Discrimination, Resolving Allele Phasing, Reproductive Genomics, Cancer, Viral & Microbial Sequencing and Others, Market Size (USD million), 2018-2028

> Segmentation by End User

· Adult Academic Research, Clinical Research, Hospitals, Clinics, and Pharma & Biotech Entities, Market Size (USD million), 2018-2028

> Segmentation by Region

· North America Long Read Sequencing Market Outlook

§ Segmentation by Technology

o Single-molecule Real-time Sequencing (SMRT) and Nanopore Sequencing, Market Size (USD million), 2018-2028

§ Segmentation by Product

o Instruments, Consumables and Services, Market Size (USD million), 2018-2028

§ Segmentation by Workflow

o Pre-sequencing, Sequencing and Data Analysis, Market Size (USD million), 2018-2028

§ Segmentation by Application

o Identification & Fine Mapping Of Structural Variation, Tandem Repeat Sequencing, Pseudogene Discrimination, Resolving Allele Phasing, Reproductive Genomics, Cancer, Viral & Microbial Sequencing and Others, Market Size (USD million), 2018-2028

§ Segmentation by End User

o Adult Academic Research, Clinical Research, Hospitals, Clinics, and Pharma & Biotech Entities, Market Size (USD million), 2018-2028

§ Segmentation by Country

o U.S. & Canada Long Read Sequencing Market, 2018-2028F (USD million)

· Europe Long Read Sequencing Market Outlook

§ Segmentation by Technology

o Single-molecule Real-time Sequencing (SMRT) and Nanopore Sequencing, Market Size (USD million), 2018-2028

§ Segmentation by Product

o Instruments, Consumables and Services, Market Size (USD million), 2018-2028

§ Segmentation by Workflow

o Pre-sequencing, Sequencing and Data Analysis, Market Size (USD million), 2018-2028

§ Segmentation by Application

o Identification & Fine Mapping Of Structural Variation, Tandem Repeat Sequencing, Pseudogene Discrimination, Resolving Allele Phasing, Reproductive Genomics, Cancer, Viral & Microbial Sequencing and Others, Market Size (USD million), 2018-2028

§ Segmentation by End User

o Adult Academic Research, Clinical Research, Hospitals, Clinics, and Pharma & Biotech Entities, Market Size (USD million), 2018-2028

§ Segmentation by Country

o UK, Germany, France, Italy, Spain, Russia and Rest of Europe Long Read Sequencing  Market, 2018-2028F (USD million)

· Asia Pacific Long Read Sequencing Market Outlook

§  Segmentation by Technology

o Single-molecule Real-time Sequencing (SMRT) and Nanopore Sequencing, Market Size (USD million), 2018-2028

§ Segmentation by Product

o Instruments, Consumables and Services, Market Size (USD million), 2018-2028

§ Segmentation by Workflow

o Pre-sequencing, Sequencing and Data Analysis, Market Size (USD million), 2018-2028

§ Segmentation by Application

o Identification & Fine Mapping Of Structural Variation, Tandem Repeat Sequencing, Pseudogene Discrimination, Resolving Allele Phasing, Reproductive Genomics, Cancer, Viral & Microbial Sequencing and Others, Market Size (USD million), 2018-2028

§ Segmentation by End User

o Adult Academic Research, Clinical Research, Hospitals, Clinics, and Pharma & Biotech Entities, Market Size (USD million), 2018-2028

§ Segmentation by Country

o China, India, Japan, South Korea, Australia, Malaysia and Rest of Asia Pacific Long Read Sequencing Market, 2018-2028F (USD million)

· Latin America Long Read Sequencing Market Outlook

§ Segmentation by Technology

o Single-molecule Real-time Sequencing (SMRT) and Nanopore Sequencing, Market Size (USD million), 2018-2028

§ Segmentation by Product

o Instruments, Consumables and Services, Market Size (USD million), 2018-2028

§ Segmentation by Workflow

o Pre-sequencing, Sequencing and Data Analysis, Market Size (USD million), 2018-2028

§ Segmentation by Application

o Identification & Fine Mapping Of Structural Variation, Tandem Repeat Sequencing, Pseudogene Discrimination, Resolving Allele Phasing, Reproductive Genomics, Cancer, Viral & Microbial Sequencing and Others, Market Size (USD million), 2018-2028

§ Segmentation by End User

o Adult Academic Research, Clinical Research, Hospitals, Clinics, and Pharma & Biotech Entities, Market Size (USD million), 2018-2028

§ Segmentation by Country

o Brazil, Mexico & Rest of Latin America Long Read Sequencing Market, 2018-2028F (USD million)

· Middle East & Africa Long Read Sequencing Market Outlook

§ Segmentation by Technology

o Single-molecule Real-time Sequencing (SMRT) and Nanopore Sequencing, Market Size (USD million), 2018-2028

§ Segmentation by Product

o Instruments, Consumables and Services, Market Size (USD million), 2018-2028

§ Segmentation by Workflow

o Pre-sequencing, Sequencing and Data Analysis, Market Size (USD million), 2018-2028

§ Segmentation by Application

o Identification & Fine Mapping Of Structural Variation, Tandem Repeat Sequencing, Pseudogene Discrimination, Resolving Allele Phasing, Reproductive Genomics, Cancer, Viral & Microbial Sequencing and Others, Market Size (USD million), 2018-2028

§ Segmentation by End User

o Adult Academic Research, Clinical Research, Hospitals, Clinics, and Pharma & Biotech Entities, Market Size (USD million), 2018-2028

§ Segmentation by Country

o United Arab Emirates, Saudi Arabia, Israel, South Africa and Rest of Middle East & Africa Long Read Sequencing Market, 2018-2028F (USD million)

11. Competitive Landscape

> Market Share Analysis by Manufacturer

> Company Profiles

· Oxford Nanopore Technologies

· Pacific Biosciences of California, Inc.

· FG Technologies

· Stratos Genomics

· QIAGEN

· Takara Bio Inc.

· Quantapore, Inc.

· BaseClear B.V.

12. Strategic Recommendations


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2020 Research Nester. All Rights Reserved